Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001967940-25-000034
Filing Date
2025-06-09
Accepted
2025-06-09 17:45:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2992
  Complete submission text file 0001967940-25-000034.txt   4570
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE #210 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE #210 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Subject) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41002 | Film No.: 251035270
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TEVOGEN BIO HOLDINGS INC. 15 INDEPENDENCE BLVD, SUITE 210 WARREN NJ 07059
Business Address
Saadi Ryan H. (Reporting) CIK: 0002011728 (see all company filings)

Type: 144